Annual report pursuant to Section 13 and 15(d)

Intangible Assets, net (Details Narrative)

v3.22.4
Intangible Assets, net (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Oct. 05, 2021
Dec. 31, 2022
Dec. 31, 2021
Apr. 02, 2022
Impairment Effects on Earnings Per Share [Line Items]        
Intangible assets   $ 5,305    
Accumulated amortization   (1,860)    
Amortization expense of intangible assets   $ 1,649 $ 0  
Defensive Technology [Member] | Pavmed Inc [Member]        
Impairment Effects on Earnings Per Share [Line Items]        
Intangible assets       $ 2,100
Accumulated amortization       $ 200
Purchase consideration paid $ 2,100      
Finite lived intangible asset useful life   60 months